Current concepts in pediatric liver transplantation

Mount Sinai Journal of Medicine

Volumn 79, Issue 2, 2012, Pages 199-213

  Emre, Sukru ^a   Umman, Veysel ^a   Cimsit, Bayindir ^a   Rosencrantz, Richard ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biliary atresia; Living donor liver transplantation; Pediatric end stage liver disease; Pediatric liver transplantation; Split liver transplantation; Surgical technique

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIBODY; DACLIZUMAB; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADRENAL INSUFFICIENCY; ALLERGIC REACTION; ANAPHYLAXIS; BILE DUCT ATRESIA; BLEEDING; BONE MARROW SUPPRESSION; BURNING SENSATION; CHILD CARE; CHILL; CLINICAL EVALUATION; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; DIABETES MELLITUS; DIARRHEA; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG WITHDRAWAL; DYSURIA; END STAGE LIVER DISEASE; FATIGUE; FEVER; GLAUCOMA; GLOMERULONEPHRITIS; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; GROWTH DISORDER; HAIR LOSS; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERTENSION; INFECTIOUS COMPLICATION; INFLUENZA; INSOMNIA; LIVER TRANSPLANTATION; LIVING DONOR; LIVING DONOR LIVER TRANSPLANTATION; MENTAL DISEASE; MOUTH ULCER; NAUSEA; NEPHROTOXICITY; NEUROLOGIC DISEASE; NEUTROPENIA; OBESITY; OSTEOPOROSIS; OUTCOME ASSESSMENT; PATIENT SELECTION; PEDIATRIC SURGERY; PLEURA EFFUSION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PROTEINURIA; REDUCED SIZE LIVER TRANSPLANTATION; REVIEW; SEIZURE; SPLIT LIVER TRANSPLANTATION; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREMOR; VOMITING; WEAKNESS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 84859790267     PISSN: 00272507     EISSN: 19317581     Source Type: Journal    
DOI: 10.1002/msj.21305     Document Type: Review

References (81)

1. Organ Procurement and Transplantation Network. http://optn.transplant. hrsa.gov. Accessed November 20, 2011.
2. Starzl TE, Marhchioro TL, von Kaulla K, et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117: 659-676.
3. Calne RY, Rolles K, White DJ, et al. Cyclosporine A initially as the only immunosuppressant in 36 recipients of cadaveric organs: 32 kidney, 2 pancreas and 3 livers. Lancet 1979; 2: 1033-1036. (Pubitemid 10213970)
4. Starzl TE, Esquivel C, Gordon R, et al. Pediatric liver transplantation. Transplant Proc 1987; 19: 3230-3235. (Pubitemid 17139820)
5. US Department of Health and Human Services, Health Resources and Services Administration.2009 OPTN/SRTR Annual Report: Transplant data 1999-2008. http://www.ustransplant.org/annual- reports/current. Accessed October 7, 2011.
6. Emond JC, Whitington PF, Thistlethwaite JR, et al. Transplantation of two patients with one liver: analysis of preliminary experience with split-liver grafting. Ann Surg 1990; 212: 14-22. (Pubitemid 20215910)
7. Bismuth H, Houssin D. Reduced-sized orthotopic liver graft in hepatic transplantation in children. Surgery 1984; 95: 367-370. (Pubitemid 14195264)
8. Pichlmayr R, Ringe B, Gubernatis G, et al. Transplantation of a donor liver to 2 recipients (splitting transplantation)-a new method in the further development of segmental liver transplantation [article in German]. Langenbecks Arch Chir 1988; 373: 127-130.
9. Bismuth H, Morino M, Castaing D, et al. Emergency orthotopic liver transplantation in two patients using one donor liver. Br J Surg 1989; 76: 722-724. (Pubitemid 19188784)
10. Rogiers X, Malagó M, Gawad K, et al. In situ splitting of cadaveric livers: the ultimate expansion of a limited donor pool. Ann Surg 1996; 224: 331-339.
11. Raia S, Nery J, Mies S. Liver transplantation from live donors. Lancet 1989; 2: 497. (Pubitemid 19209155)
12. Strong RW, Lynch SV, Ong TH, et al. Successful liver transplantation from a living donor to her son. N Engl J Med 1990; 322: 1505-1507. (Pubitemid 20179865)
13. Broelsch CE, Whitington PF, Emond JC, et al. Liver transplantation in children from living related donors: surgical techniques and results. Ann Surg 1991; 214: 428-439.
14. Cox K, Berquist WE, Castillo RO. Paediatric liver transplantation: indications, timing and medical complications. J Gastroenterol Hepatol 1999; 14(suppl): S61-S66. (Pubitemid 29281868)
15. Kasai M. Treatment of biliary atresia with special reference to hepatic porto-enterostomy and its modifications. Prog Pediatr Surg 1974; 6: 5-52.
16. Khalil BA, Perera MT, Mirza DF. Clinical practice: management of biliary atresia. Eur J Pediatr 2010; 169: 395-402.
17. De Vries W, de Langen ZJ, Groen H, et al Netherlands Study Group of Biliary Atresia and Registry (NeSBAR). Biliary atresia in The Netherlands: outcome of patients diagnosed between 1987 and 2008. J Pediatr 2011; doi: 10.1016/j.jpeds.2011.09.061.
18. Shneider BL, Mazariegos GV. Biliary atresia: a transplant perspective. Liver Transpl 2007; 13: 1482-1495. (Pubitemid 350168185)
19. McDiarmid SV, Anand R, Lindblad AS; Principal Investigators and Institutions of the Studies of Pediatric Liver Transplantation (SPLIT) Research Group. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 2002; 74: 173-181. (Pubitemid 34810283)
20. Shneider BL, Suchy FJ, Emre S. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004). Liver Transpl 2006; 12: 40-45.
21. Chin SE, Shepherd RW, Thomas BJ, et al. The nature of malnutrition in children with end-stage liver disease awaiting orthotopic liver transplantation. Am J Clin Nutr 1992; 56: 164-168.
22. Greer R, Lehnert M, Lewindon P, et al. Body composition and components of energy expenditure in children with end-stage liver disease. J Pediatr Gastroenterol Nutr 2003; 36: 358-363. (Pubitemid 39274607)
23. Bucuvalas JC, Horn JA, Slusher J, et al. Growth hormone insensitivity in children with biliary atresia. J Pediatr Gastroenterol Nutr 1996; 23: 135-140. (Pubitemid 26269755)
24. Utterson EC, Shepherd RW, Sokol RJ, et al SPLIT Research Group. Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation. J Pediatr 2005; 147: 180-185. (Pubitemid 41207830)
25. Eroglu Y, Emerick KM, Whitingon PF, et al. Octreotide therapy for control of acute gastrointestinal bleeding in children. J Pediatr Gastroenterol Nutr 2004; 38: 41-47. (Pubitemid 39274466)
26. Miga D, Sokol RJ, Mackenzie T, et al. Survival after first esophageal variceal hemorrhage in patients with biliary atresia. J Pediatr 2001; 139: 291-296. (Pubitemid 32721720)
27. Ozsoylu S, Koçak N, Demir H, et al. Propranolol for primary and secondary prophylaxis of variceal bleeding in children with cirrhosis. Turk J Pediatr 2000; 42: 31-33. (Pubitemid 30143322)
28. Shneider B, Emre S, Groszmann R, et al. Expert pediatric opinion on the Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. Pediatr Transplant 2006; 10: 893-907. (Pubitemid 44683633)
29. Deen JL, Blumberg DA. Infectious disease considerations in pediatric organ transplantation. Semin Pediatr Surg 1993; 2: 218-234.
30. Hollenbeak CS, Alfrey EJ, Sheridan K, et al. Surgical site infections following pediatric liver transplantation: risks and costs. Transpl Infect Dis 2003; 5: 72-78. (Pubitemid 37221470)
31. Jovine E, Mazziotti A, Grazi GL, et al. Piggy-back versus conventional technique in liver transplantation: report of a randomized trial. Transpl Int 1997; 10: 109-112. (Pubitemid 27110499)
32. Moreno-Gonzalez E, Meneu-Diaz JG, Fundora Y, et al. Advantages of the piggy back technique on intraoperative transfusion, fluid consumption, and vasoactive drugs requirements in liver transplantation: a comparative study. Transplant Proc 2003; 35: 1918-1919. (Pubitemid 37093764)
33. Vazquez J, López Gutierrez JC, Gámez M, et al. Biliary atresia and the polysplenia syndrome: its impact on final outcome. J Pediatr Surg 1995; 30: 485-487.
34. Sindhi R, Rosendale J, Mundy D, et al. Impact of segmental grafts on pediatric liver transplantation-a review of the United Network for Organ Sharing Scientific Registry data (1990-1996). J Pediatr Surg 1999;34:107-110.
35. Broelsch CE, Emond JC, Whitington PF, et al. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 1990; 212: 368-377. (Pubitemid 20289359)
36. Spada M, Riva S, Maggiore G, et al. Pediatric liver transplantation. World J Gastroenterol 2009; 15: 648-674.
37. Ghobrial RM, Yersiz H, Farmer DG, et al. Predictors of survival after in vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg 2000; 232: 312-323.
38. Yersiz H, Renz JF, Farmer DG, et al. One hundred in situ split-liver transplantations: a single-center experience. Ann Surg 2003; 238: 496-507. (Pubitemid 38176387)
39. Gridelli B, Spada M, Petz W, et al. Split-liver transplantation eliminates the need for living-donor liver transplantation in children with end-stage cholestatic liver disease. Transplantation 2003; 75: 1197-1203. (Pubitemid 36513021)
40. Emre S, Umman V. Split liver transplantation: an overview. Transplant Proc 2011; 43: 884-887.
41. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790. (Pubitemid 43345017)
42. Fan ST, Wei WI, Yong BH, et al. Living Donor Liver Transplantation. 2nd ed. London, UK: World Scientific Publishing Co. Ltd; 2011.
43. Emre S. Living-donor liver transplantation in children. Pediatr Transplant 2002; 6: 43-46. (Pubitemid 34269735)
44. Stringer MD, Marshall MM, Muiesan P, et al. Survival and outcome after hepatic artery thrombosis complicating pediatric liver transplantation. J Pediatr Surg 2001; 36: 888-891. (Pubitemid 32496896)
45. Sunku B, Salvalaggio PR, Donaldson JS, et al. Outcomes and risk factors for failure of radiologic treatment of biliary strictures in pediatric liver transplantation recipients. Liver Transpl 2006; 12: 821-826.
46. Diamond IR, Fecteau A, Millis JM, et al SPLIT Research Group. Impact of graft type on outcome in pediatric liver transplantation: a report from Studies of Pediatric Liver Transplantation (SPLIT). Ann Surg 2007; 246: 301-310.
47. Uchida Y, Sakamoto S, Egawa H, et al. The impact of meticulous management for hepatic artery thrombosis on long-term outcome after pediatric living donor liver transplantation. Clin Transplant 2009; 23: 392-399.
48. Panossian A, Diamond I, Fecteau A, et al. Hepatic artery microvascular anastomosis in pediatric living donor liver transplantation: a review of 35 consecutive cases by a single microvascular surgeon. J Reconstr Microsurg 2009; 25: 439-443.
49. Martin SR, Atkison P, Anand R, et al SPLIT Research Group. Studies of pediatric liver transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Pediatr Transplant 2004; 8: 273-283. (Pubitemid 38788556)
50. Tiao GM, Alonso M, Bezerra J, et al. Liver transplantation in children younger than 1 year-the Cincinnati experience. J Pediatr Surg 2005; 40: 268-273. (Pubitemid 40143570)
51. Mazzaferro V, Esquivel CO, Makowka L, et al. Factors responsible for hepatic artery thrombosis after pediatric liver transplantation. Transplant Proc 1989; 21(1 part 2): 2466-2467. (Pubitemid 19131299)
52. Bekker J, Ploem S, de Jong KP. Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant 2009; 9: 746-757.
53. Cheng YF, Chen CL, Huang TL, et al. 3DCT angiography for detection of vascular complications in paediatric liver transplantation. Liver Transpl 2004; 10: 248-252. (Pubitemid 38240124)
54. Sevmis S, Karakayali H, Tutar NU, et al. Management of early hepatic arterial thrombosis after pediatric living-donor liver transplantation. Transplant Proc 2011; 43: 605-608.
55. Grodzicki M, Anysz-Grodzicka A, Remiszewski P, et al. Treatment of early hepatic artery thrombosis after liver transplantation. Transplant Proc 2011; 43: 3039-3042.
56. Singhal A, Stokes K, Sebastian A, et al. Endovascular treatment of hepatic artery thrombosis following liver transplantation. Transpl Int 2010; 23: 245-256.
57. Zhou J, Fan J, Wang JH, et al. Continuous transcatheter arterial thrombolysis for early hepatic artery thrombosis after liver transplantation. Transplant Proc 2005; 37: 4426-4429. (Pubitemid 43016048)
58. Sabri SS, Saad WE, Schmitt TM, et al. Endovascular therapy for hepatic artery stenosis and thrombosis following liver transplantation. Vasc Endovascular Surg 2011; 45: 447-452.
59. Yamanaka J, Lynch SV, Ong TH, et al. Surgical complications and long-term outcome in pediatric liver transplantation. Hepatogastroenterology 2000; 47: 1371-1374.
60. Kamath BM, Olthoff KM. Liver transplantation in children: update 2010. Pediatr Clin North Am 2010; 57: 401-414.
61. Buell JF, Funaki B, Cronin DC, et al. Long-term venous complications after full-size and segmental pediatric liver transplantation. Ann Surg 2002; 236: 658-666. (Pubitemid 35246899)
62. Sieders E, Peeters PM, TenVergert EM, et al. Graft loss after pediatric liver transplantation. Ann Surg 2002; 235: 125-132. (Pubitemid 34062408)
63. Bourdeaux C, Darwish A, Jamart J, et al. Living-related versus deceased donor pediatric liver transplantation: a multivariate analysis of technical and immunological complications in 235 recipients. Am J Transplant 2007; 7: 440-447. (Pubitemid 46096338)
64. Ueda M, Egawa H, Ogawa K, et al. Portal vein complications in the long-term course after pediatric living donor liver transplantation. Transplant Proc 2005; 37: 1138-1140. (Pubitemid 40590815)
65. Broering DC, Kim JS, Mueller T, et al. One hundred thirty-two consecutive pediatric liver transplants without hospital mortality: lessons learned and outlook for the future. Ann Surg 2004; 240: 1002-1012. (Pubitemid 39602128)
66. Takatsuki M, Chen CL, Chen YS, et al. Systemic thrombolytic therapy for late-onset portal vein thrombosis after living-donor liver transplantation. Transplantation 2004; 77: 1014-1018. (Pubitemid 38508915)
67. Millis JM, Seaman DS, Piper JB, et al. Portal vein thrombosis and stenosis in pediatric liver transplantation. Transplantation 1996; 62: 748-754. (Pubitemid 26332836)
68. Kishi Y, Sugawara Y, Matsui Y, et al. Late-onset portal vein thrombosis and its risk factors. Hepatogastroenterology 2008; 55: 1008-1009. (Pubitemid 351975976)
69. Heffron TG, Pillen T, Smallwood G, et al. Incidence, impact, and treatment of portal and hepatic venous complications following pediatric liver transplantation: a single-center 12 year experience. Pediatr Transplant 2010; 14: 722-729.
70. Emre S, Gondolesi G, Polat K, et al. Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl 2001; 7: 220-225. (Pubitemid 32243817)
71. Tannuri U, Gibelli NE, Maksoud-Filho JG, et al. Mycophenolate mofetil promotes prolonged improvement of renal dysfunction after pediatric liver transplantation: experience of a single center. Pediatr Transplant 2007; 11: 82-86. (Pubitemid 46100960)
72. Evans HM, McKiernan PJ, Kelly DA. Mycophenolate mofetil for renal dysfunction after pediatric liver transplantation. Transplantation 2005; 79: 1575-1580. (Pubitemid 40847590)
73. Dell-Olio D, Kelly DA. Calcineurin inhibitor minimization in pediatric liver allograft recipients. Pediatr Transplant 2009; 13: 670-681.
74. Sindhi R, Ganjoo J, McGhee W, et al. Preliminary immunosuppression withdrawal strategies with sirolimus in children with liver transplants. Transplant Proc 2002; 34: 1972-1973.
75. Neuberger JM, Mamelok RD, Neuhaus P, et al. Delayed introduction of reduced-dose tacrolimus, and renalfunction in liver transplantation: the 'ReSpECT' study. Am J Transplant 2009; 9: 327-336.
76. Arora N, McKiernan PJ, Beath SV, et al. Concomitant basiliximab with low-dose calcineurin inhibitors in children post-liver transplantation. Pediatr Transplant 2002; 6: 214-218. (Pubitemid 34836277)
77. Kogan-Liberman D, Burroughs M, Emre S, et al. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience. J Pediatr Gastroenterol Nutr 2001; 33: 445-449. (Pubitemid 33070098)
78. Lee TC, Savoldo B, Rooney CM, et al. Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant 2005; 5: 2222-2228. (Pubitemid 41648469)
79. Hübscher S. What does the long-term liver allograft look like for the pediatric recipient? Liver Transpl 2009; 15(suppl 2): S19-S24.
80. Ekong UD, Melin-Aldana H, Seshadri R, et al. Graft histology characteristics in long-term survivors of pediatric liver transplantation. Liver Transpl 2008; 14: 1582-1587.
81. Scheenstra R, Peeters PM, Verkade HJ, et al. Graft fibrosis after pediatric liver transplantation: ten years of follow-up. Hepatology 2009; 49: 880-886.